Integrating Blood-Based Biomarkers & Digital Cognitive Assessments to Accelerate Brain Health Research
The Convergence: Integrating Blood Biomarker Tests and Digital Cognition to Accelerate Alzheimer’s Research The paradigm for diagnosing and monitoring Alzheimer’s disease (AD) is shifting from relying on clinical symptoms to incorporating definitive biological evidence of amyloid and tau proteinopathy. As discussed in our recent joint webinar with C2N Diagnostics and the AI-Mind project, combining blood […]
